Stem-Cell 3D Spheroid Extracellular Vesicles for Angiogenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing extracellular vesicles from stem cells are inefficient and lack efficacy enhancement, posing safety concerns and requiring improved production processes.
Innovation Solution
A method involving 3D culture of stem cells in microwells to form spheroid-type cell aggregates, followed by isolation of extracellular vesicles, which enhances angiogenesis promotion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stem cells are used for therapy, then regenerative effect is improved, but safety deteriorates due to side effects such as vascular occlusion and tumor formation
Solution Approach 1:
The invention extracts and isolates extracellular vesicles from stem cells, separating the therapeutic active components from the cellular structures that cause side effects. This allows the therapeutic benefits to be retained while eliminating harmful effects such as vascular occlusion and tumor formation associated with whole stem cell transplantation
Solution Approach 2:
The invention creates a copy of the therapeutic mechanism by isolating extracellular vesicles that carry and transfer the regenerative signals originally produced by stem cells. These vesicles replicate the paracrine effects of stem cells without requiring the presence of living stem cells, thereby avoiding their associated risks
2Productivity
If conventional methods are used to produce extracellular vesicles, then production is simplified, but productivity deteriorates due to lack of established mass production methods
Solution Approach 1:
The invention segments the production process into distinct stages: stem cell culture, extracellular vesicle secretion induction, vesicle isolation, and purification. This segmentation enables each step to be optimized independently and facilitates scaling to mass production while maintaining control over process complexity
Solution Approach 2:
The invention employs parameter changes in the culture system, including optimizing cell density, medium composition, and culture conditions to maximize extracellular vesicle secretion. These parameter optimizations enable high-yield production while maintaining a manageable manufacturing process
3Reliability
If culture time is extended to improve extracellular vesicle quality, then angiogenesis promotion is improved, but production efficiency deteriorates due to prolonged culture time
Solution Approach 1:
The invention applies preliminary actions by pre-conditioning stem cells and optimizing culture conditions before extracellular vesicle harvest to accelerate vesicle secretion and maturation. This reduces the required culture time while ensuring high-quality vesicles with strong angiogenesis promotion capability
Solution Approach 2:
The invention employs periodic action through pulsed or cyclic culture conditions that stimulate extracellular vesicle secretion at specific intervals. This approach maintains high vesicle quality and angiogenic activity while reducing overall culture time compared to continuous long-term culture
Data Source
AI summary
The present invention relates to: a composition for promoting angiogenesis, comprising extracellular vesicles derived from a three-dimensional spheroid-type cell aggregate that are produced using a novel production method; and a method for promoting angiogenesis. The extracellular vesicles produced by a novel method of the present invention highly express various factors capable of promoting angiogenesis and can induce the regeneration of blood vessels, and thus can be effectively used in the treatment of various diseases that require vascular regeneration.